195 related articles for article (PubMed ID: 18336930)
21. Differences in behavioural test battery performance between mice with hippocampal and cerebellar lesions.
Goddyn H; Leo S; Meert T; D'Hooge R
Behav Brain Res; 2006 Oct; 173(1):138-47. PubMed ID: 16860407
[TBL] [Abstract][Full Text] [Related]
22. Metachromatic leukodystrophy: subtype genotype/phenotype correlations and identification of novel missense mutations (P148L and P191T) causing the juvenile-onset disease.
Qu Y; Shapira E; Desnick RJ
Mol Genet Metab; 1999 Jul; 67(3):206-12. PubMed ID: 10381328
[TBL] [Abstract][Full Text] [Related]
23. Delay of myelin formation in arylsulphatase A-deficient mice.
Yaghootfam A; Gieselmann V; Eckhardt M
Eur J Neurosci; 2005 Feb; 21(3):711-20. PubMed ID: 15733089
[TBL] [Abstract][Full Text] [Related]
24. Missense mutations as a cause of metachromatic leukodystrophy. Degradation of arylsulfatase A in the endoplasmic reticulum.
Poeppel P; Habetha M; Marcão A; Büssow H; Berna L; Gieselmann V
FEBS J; 2005 Mar; 272(5):1179-88. PubMed ID: 15720392
[TBL] [Abstract][Full Text] [Related]
25. Decline in brainstem auditory-evoked potentials coincides with loss of spiral ganglion cells in arylsulfatase A-deficient mice.
D'Hooge R; Coenen R; Gieselmann V; Lüllmann-Rauch R; De Deyn PP
Brain Res; 1999 Nov; 847(2):352-6. PubMed ID: 10575108
[TBL] [Abstract][Full Text] [Related]
26. Adult onset metachromatic leukodystrophy without electroclinical peripheral nervous system involvement: a new mutation in the ARSA gene.
Marcão AM; Wiest R; Schindler K; Wiesmann U; Weis J; Schroth G; Miranda MC; Sturzenegger M; Gieselmann V
Arch Neurol; 2005 Feb; 62(2):309-13. PubMed ID: 15710861
[TBL] [Abstract][Full Text] [Related]
27. Novel mutations in arylsulfatase A gene in three Ukrainian families with metachromatic leukodystrophy.
Olkhovich NV; Takamura N; Pichkur NA; Gorovenko NG; Aoyagi K; Yamashita S
Mol Genet Metab; 2003 Nov; 80(3):360-3. PubMed ID: 14680985
[TBL] [Abstract][Full Text] [Related]
28. Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy.
Ramakrishnan H; Hedayati KK; Lüllmann-Rauch R; Wessig C; Fewou SN; Maier H; Goebel HH; Gieselmann V; Eckhardt M
J Neurosci; 2007 Aug; 27(35):9482-90. PubMed ID: 17728461
[TBL] [Abstract][Full Text] [Related]
29. Induction of tolerance to human arylsulfatase A in a mouse model of metachromatic leukodystrophy.
Matzner U; Matthes F; Herbst E; Lüllmann-Rauch R; Callaerts-Vegh Z; D'Hooge R; Weigelt C; Eistrup C; Fogh J; Gieselmann V
Mol Med; 2007; 13(9-10):471-9. PubMed ID: 17660863
[TBL] [Abstract][Full Text] [Related]
30. Metachromatic leukodystrophy: molecular genetics and an animal model.
Gieselmann V; Matzner U; Hess B; Lüllmann-Rauch R; Coenen R; Hartmann D; D'Hooge R; DeDeyn P; Nagels G
J Inherit Metab Dis; 1998 Aug; 21(5):564-74. PubMed ID: 9728336
[TBL] [Abstract][Full Text] [Related]
31. Multivariate neurocognitive and emotional profile of a mannosidosis murine model for therapy assessment.
Caeyenberghs K; Balschun D; Roces DP; Schwake M; Saftig P; D'Hooge R
Neurobiol Dis; 2006 Aug; 23(2):422-32. PubMed ID: 16766199
[TBL] [Abstract][Full Text] [Related]
32. Behavioural phenotyping reveals anxiety-like features of SV2A deficient mice.
Lamberty Y; Detrait E; Leclercq K; Michel A; De Ryck M
Behav Brain Res; 2009 Mar; 198(2):329-33. PubMed ID: 19041904
[TBL] [Abstract][Full Text] [Related]
33. Occurrence, distribution, and phenotype of arylsulfatase A mutations in patients with metachromatic leukodystrophy.
Berger J; Löschl B; Bernheimer H; Lugowska A; Tylki-Szymanska A; Gieselmann V; Molzer B
Am J Med Genet; 1997 Mar; 69(3):335-40. PubMed ID: 9096767
[TBL] [Abstract][Full Text] [Related]
34. Metachromatic leukodystrophy--an update.
Gieselmann V; Krägeloh-Mann I
Neuropediatrics; 2010 Feb; 41(1):1-6. PubMed ID: 20571983
[TBL] [Abstract][Full Text] [Related]
35. Assessing behavioural function following a pyramidotomy lesion of the corticospinal tract in adult mice.
Starkey ML; Barritt AW; Yip PK; Davies M; Hamers FP; McMahon SB; Bradbury EJ
Exp Neurol; 2005 Oct; 195(2):524-39. PubMed ID: 16051217
[TBL] [Abstract][Full Text] [Related]
36. On a rare atypical form of metachromatic leukodystrophy (MLD): "neurological non-mld patients with low levels of arylsulphatase A". Description of two cases.
Grasso A; Fiumara A; Biondi R; Nigro F; Nardone G; Bonomo MG; Sicurella L; Scrofani A
Acta Neurol (Napoli); 1989 Aug; 11(4):233-8. PubMed ID: 2572149
[TBL] [Abstract][Full Text] [Related]
37. [Molecular screening of the major mutations in the ARSA gene in patients with metachromatic leukodystrophy].
Horovenko NH; Ol'khovych NV; Pichkur NO
Tsitol Genet; 2002; 36(5):43-8. PubMed ID: 12442547
[TBL] [Abstract][Full Text] [Related]
38. Arylsulfatase A pseudodeficiency incidence in Turkey.
Emre S; Topçu M; Terzioğlu M; Renda Y
Turk J Pediatr; 2000; 42(2):115-7. PubMed ID: 10936976
[TBL] [Abstract][Full Text] [Related]
39. Accumulation of lysosulfatide in the brain of arylsulfatase A-deficient mice.
Blomqvist M; Gieselmann V; Månsson JE
Lipids Health Dis; 2011 Feb; 10():28. PubMed ID: 21299873
[TBL] [Abstract][Full Text] [Related]
40. Long-term correction of biochemical and neurological abnormalities in MLD mice model by neonatal systemic injection of an AAV serotype 9 vector.
Miyake N; Miyake K; Asakawa N; Yamamoto M; Shimada T
Gene Ther; 2014 Apr; 21(4):427-33. PubMed ID: 24572788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
